[Infusion urography with joxitalmat comparative study with different infusion solutions (author's transl)].
In a total of 157 patients, comparative infusion urography was conducted using different concentrations of the same infusion substance Joxitalmat (Telebrix). No fatal or severe side effects caused by the contrast medium were seen. Infusion of the 66% contrast medium solution C produced mild side effects in 9% of the patients, whereas 4% resp. 2% side effects occurred with the solutions A (39.7%) and B (36.6%). Hence, solutions A and B appear to be more appropriate for clinical diagnostics, the diagnostic value being approximately the same for all three solutions under investigation.
D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D007263:Infusions, Parenteral; D007482:Iothalamate Meglumine / Q000009:adverse effects; D014567:Urography / Q000379:methods*
D007482:Iothalamate Meglumine
Infusionsurographie mit Joxitalmat Vergleichende Untersuchungen mit verschiedenen Infusionslösungen.